黄芪注射液治疗心律失常患者的临床疗效

The Clinical Efficacy of the Treatment of Patients with Arrhythmia Huangqi

目的探讨黄芪注射液治疗心律失常患者的临床疗效。方法将190例严重心律失常患者按随机数字表法分为观察组和对照组,各95例。对照组患者给予常规抗心律失常、溶栓、降脂、抗凝、抗血小板聚集治疗,观察组患者在对照组治疗基础上加用黄芪注射液治疗。比较两组患者的治疗效果及心肌酶谱。结果观察组患者总有效率高于对照组,血清乳酸脱氢酶(LDH)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、天冬氨酸转氨酶(AST)均低于对照组(P<0.05)。结论在常规治疗基础上加用黄芪注射液治疗,可有效缓解心律失常患者的临床症状,改善心功能,提高临床治疗效果。

Objective To investigate the clinical efficacy of astragalus injection treating arrhythmia patients.Methods 190 cases of severe arrhythmia patients were randomly divided into observation group and control group, 95 cases.In the control group were treated with conventional anti-arrhythmia,thrombolysis,lipid-lowering,anticoagulant,anti-platelet aggregation therapy was observed in patients astragalus injection therapy in the control group basis.Treatment and myocardial enzymes were compared indicators of the patient.Results Observation group were higher than the total efficiency,serum lactate dehydrogenase（LDH）,creatine kinase（CK）,creatine kinase（CK-MB）, aspartate aminotransferase（AST）were low in the control group（P〈0.05）.Conclusions Based on conventional therapy plus astragalus treatment can effectively relieve symptoms of patients with arrhythmia,improve heart function, improve clinical outcomes..